Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1986 1
1989 2
1991 2
1992 2
1993 3
1994 1
1996 1
1998 4
2001 2
2003 2
2006 2
2007 1
2008 2
2009 1
2010 1
2013 1
2014 1
2015 1
2016 3
2017 2
2019 3
2020 2
2021 2
2022 1
2023 3
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Active learning-assisted directed evolution.
Yang J, Lal RG, Bowden JC, Astudillo R, Hameedi MA, Kaur S, Hill M, Yue Y, Arnold FH. Yang J, et al. Among authors: astudillo r. Nat Commun. 2025 Jan 16;16(1):714. doi: 10.1038/s41467-025-55987-8. Nat Commun. 2025. PMID: 39821082 Free PMC article.
Caplacizumab for relapsing thrombotic thrombocytopenic purpura.
Kaczmarek V, Holle J, Astudillo R, Kempf C, Bufler P, Müller D. Kaczmarek V, et al. Among authors: astudillo r. Pediatr Nephrol. 2019 Sep;34(9):1625-1628. doi: 10.1007/s00467-019-04281-z. Epub 2019 Jun 8. Pediatr Nephrol. 2019. PMID: 31177334
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial.
Heinrich N, Manyama C, Koele SE, Mpagama S, Mhimbira F, Sebe M, Wallis RS, Ntinginya N, Liyoyo A, Huglin B, Minja LT, Wagnerberger L, Stoycheva K, Zumba T, Noreña I, Peter DD, Makkan H, Sloan DJ, Brake LT, Schildkraut J, Aarnoutse RE, McHugh TD, Wildner L, Boeree M, Aldana BH, Phillips PPJ, Hoelscher M, Svensson EM; PanACEA consortium. Heinrich N, et al. Lancet Infect Dis. 2025 Jul 8:S1473-3099(25)00213-0. doi: 10.1016/S1473-3099(25)00213-0. Online ahead of print. Lancet Infect Dis. 2025. PMID: 40645196 Free article.
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial.
Minja LT, van der Feltz I, Manyama C, Mpagama S, Mhimbira F, Noreña I, Sebe M, Rassool M, Wallis RS, Ntinginya N, Liyoyo A, Mbeya B, Wagnerberger L, Zumba T, Peter DD, Makkan H, Sloan DJ, Brake LT, Schildkraut JA, Aarnoutse R, McHugh TD, Wildner L, Boeree MJ, Geiter L, Cho YL, Aldana BH, Phillips PPJ, Hoelscher M, Svensson EM, Heinrich N; PanACEA consortium. Minja LT, et al. Lancet Infect Dis. 2025 Jul 8:S1473-3099(25)00289-0. doi: 10.1016/S1473-3099(25)00289-0. Online ahead of print. Lancet Infect Dis. 2025. PMID: 40645198 Free article.
48 results